Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel 6-alkyl-bridged 4-arylalkylpiperazin-1-yl derivatives of azepino[4,3-b]indol-1(2H)-one as potent BChE-selective inhibitors showing protective effects against neurodegenerative insults
Francesco Samarelli, Rosa Purgatorio, Gianfranco Lopopolo, et al.
European Journal of Medicinal Chemistry (2024) Vol. 270, pp. 116353-116353
Open Access | Times Cited: 10

Showing 10 citing articles:

Advances in Alzheimer's disease: A multifaceted review of potential therapies and diagnostic techniques for early detection
Monika Sharma, Pankaj Pal, Sukesh Kumar Gupta
Neurochemistry International (2024) Vol. 177, pp. 105761-105761
Closed Access | Times Cited: 16
Design, synthesis, biological evaluation, and in silico studies of imidazo[2,1-b][1,3,4]thiadiazole derivatives as cholinesterase inhibitors
Wen-Rong Du, Yixuan Wang, Xue-Wei Zhou, et al.
Medicinal Chemistry Research (2025)
Closed Access
Discovery of new dual butyrylcholinesterase (BuChE) inhibitors and 5-HT7 receptor antagonists as compounds used to treat Alzheimer’s disease symptoms
Damian Kułaga, Anna K. Drabczyk, Przemysław Zaręba, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 117995-117995
Closed Access
Role of Quinoline and Indole-Based Heterocycles in revolutionizing Alzheimer’s drug discovery – Promising futuristic structural designs
Atukuri Dorababu
Journal of Pharmacology and Experimental Therapeutics (2025), pp. 103606-103606
Closed Access
Chiral pyrrolidines as multipotent agents in Alzheimer and neurodegenerative diseases
Antonio Carrieri, Alexia Barbarossa, Modesto de Candia, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 110, pp. 117829-117829
Open Access | Times Cited: 3
Current pharmacophore based approaches for the development of new anti-Alzheimer’s agents
Prachi Sharma, Sunil Sharma, Yogesh Yadav, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 113, pp. 117926-117926
Closed Access | Times Cited: 3
Enzyme ChE, cholinergic therapy and molecular docking: Significant considerations and future perspectives
Snežana M Jovičić
International Journal of Immunopathology and Pharmacology (2024) Vol. 38
Open Access | Times Cited: 2
Design, synthesis and anti-Alzheimer's disease activity evaluation of C-3 arylated huperzine A derivatives
Xiao-Xing Zhu, Feng Gao, Lin‐Xi Wan
Fitoterapia (2024) Vol. 177, pp. 106141-106141
Closed Access | Times Cited: 1
Exploring the Pivotal Role of Pyrrolidine Ring in Search of Multipotent Agents in Neurodegenerative Diseases
Antonio Carrieri, Alexia Barbarossa, Modesto de Candia, et al.
(2024)
Closed Access
Design, Synthesis and Anti-Alzheimer's Disease Activity Evaluation of C-3 Arylated Huperzine a Derivatives
Feng Gao, Xiao-Xing Zhu, Lin‐Xi Wan
(2024)
Closed Access
Dizocilpine derivatives as neuroprotective NMDA receptor antagonists without psychomimetic side effects
Jan Konečný, Anna Misiachna, Markéta Chvojková, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116981-116981
Open Access
Page 1

Scroll to top